Clinical Trial Update: Talampanel to Treat Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating talampanel for Parkinson's disease has been completed. The study was sponsored by the National Institute of Neurological Disorders an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Talampanel (talampanel)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED